nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1B1—Mitoxantrone—sarcoma	0.102	0.131	CbGbCtD
Omeprazole—ABCC3—Vincristine—sarcoma	0.0812	0.104	CbGbCtD
Omeprazole—ABCC3—Etoposide—sarcoma	0.0744	0.0954	CbGbCtD
Omeprazole—CYP1A1—Dacarbazine—sarcoma	0.0577	0.0739	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—sarcoma	0.0542	0.0695	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—sarcoma	0.0508	0.0651	CbGbCtD
Omeprazole—ABCG2—Mitoxantrone—sarcoma	0.0485	0.0622	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—sarcoma	0.0439	0.0562	CbGbCtD
Omeprazole—ABCG2—Vincristine—sarcoma	0.0334	0.0428	CbGbCtD
Omeprazole—ABCG2—Etoposide—sarcoma	0.0306	0.0392	CbGbCtD
Omeprazole—CYP1A2—Dacarbazine—sarcoma	0.0258	0.033	CbGbCtD
Omeprazole—CYP3A4—Thiotepa—sarcoma	0.0244	0.0312	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—sarcoma	0.0209	0.0267	CbGbCtD
Omeprazole—ABCB1—Dactinomycin—sarcoma	0.0195	0.025	CbGbCtD
Omeprazole—ABCB1—Mitoxantrone—sarcoma	0.0175	0.0224	CbGbCtD
Omeprazole—CYP2C8—Etoposide—sarcoma	0.0163	0.0209	CbGbCtD
Omeprazole—CYP1A2—Etoposide—sarcoma	0.0126	0.0162	CbGbCtD
Omeprazole—ABCB1—Vincristine—sarcoma	0.012	0.0154	CbGbCtD
Omeprazole—ABCB1—Etoposide—sarcoma	0.011	0.0141	CbGbCtD
Omeprazole—CYP3A4—Mitoxantrone—sarcoma	0.0105	0.0134	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—sarcoma	0.00752	0.00964	CbGbCtD
Omeprazole—ATP4A—larynx—sarcoma	0.00729	0.211	CbGeAlD
Omeprazole—CYP3A4—Vincristine—sarcoma	0.00721	0.00924	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—sarcoma	0.00709	0.00908	CbGbCtD
Omeprazole—CYP3A4—Etoposide—sarcoma	0.00661	0.00847	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—sarcoma	0.00451	0.00578	CbGbCtD
Omeprazole—ATP4B—liver—sarcoma	0.00171	0.0496	CbGeAlD
Omeprazole—ATP4A—hematopoietic system—sarcoma	0.00144	0.0417	CbGeAlD
Omeprazole—ATP4A—connective tissue—sarcoma	0.00138	0.0401	CbGeAlD
Omeprazole—CYP11A1—hematopoietic system—sarcoma	0.000943	0.0273	CbGeAlD
Omeprazole—CYP1B1—mammary gland—sarcoma	0.00094	0.0272	CbGeAlD
Omeprazole—CYP11A1—connective tissue—sarcoma	0.000908	0.0263	CbGeAlD
Omeprazole—ATP4A—testis—sarcoma	0.000788	0.0229	CbGeAlD
Omeprazole—ATP4A—liver—sarcoma	0.000745	0.0216	CbGeAlD
Omeprazole—ABCC3—hematopoietic system—sarcoma	0.000732	0.0212	CbGeAlD
Omeprazole—CYP2C8—mammary gland—sarcoma	0.00072	0.0209	CbGeAlD
Omeprazole—CYP2C9—mammary gland—sarcoma	0.000639	0.0185	CbGeAlD
Omeprazole—CYP2C18—liver—sarcoma	0.000612	0.0178	CbGeAlD
Omeprazole—CYP1B1—hematopoietic system—sarcoma	0.000573	0.0166	CbGeAlD
Omeprazole—CYP1B1—connective tissue—sarcoma	0.000551	0.016	CbGeAlD
Omeprazole—CYP11A1—testis—sarcoma	0.000517	0.015	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—sarcoma	0.000504	0.0146	CbGeAlD
Omeprazole—CYP2C19—hematopoietic system—sarcoma	0.000502	0.0146	CbGeAlD
Omeprazole—CYP1B1—skin of body—sarcoma	0.000498	0.0144	CbGeAlD
Omeprazole—ABCG2—myometrium—sarcoma	0.000497	0.0144	CbGeAlD
Omeprazole—ABCG2—seminal vesicle—sarcoma	0.000449	0.013	CbGeAlD
Omeprazole—CYP2C8—hematopoietic system—sarcoma	0.000439	0.0127	CbGeAlD
Omeprazole—CYP1B1—uterus—sarcoma	0.000433	0.0125	CbGeAlD
Omeprazole—CYP1A2—hematopoietic system—sarcoma	0.00041	0.0119	CbGeAlD
Omeprazole—CYP1A1—hematopoietic system—sarcoma	0.000405	0.0117	CbGeAlD
Omeprazole—CYP1B1—lymphoid tissue—sarcoma	0.000403	0.0117	CbGeAlD
Omeprazole—ABCC3—testis—sarcoma	0.000401	0.0116	CbGeAlD
Omeprazole—CYP2C9—hematopoietic system—sarcoma	0.00039	0.0113	CbGeAlD
Omeprazole—ABCC3—liver—sarcoma	0.000379	0.011	CbGeAlD
Omeprazole—CYP1B1—tendon—sarcoma	0.000379	0.011	CbGeAlD
Omeprazole—CYP11A1—lymph node—sarcoma	0.000375	0.0109	CbGeAlD
Omeprazole—CYP1A1—skin of body—sarcoma	0.000352	0.0102	CbGeAlD
Omeprazole—ABCG2—uterus—sarcoma	0.000322	0.00934	CbGeAlD
Omeprazole—CYP1B1—testis—sarcoma	0.000314	0.0091	CbGeAlD
Omeprazole—CYP1A1—cardiac atrium—sarcoma	0.000307	0.00891	CbGeAlD
Omeprazole—CYP1A1—uterus—sarcoma	0.000306	0.00886	CbGeAlD
Omeprazole—CYP3A4—hematopoietic system—sarcoma	0.000297	0.00861	CbGeAlD
Omeprazole—CYP1B1—liver—sarcoma	0.000297	0.0086	CbGeAlD
Omeprazole—CYP2D6—hematopoietic system—sarcoma	0.000292	0.00847	CbGeAlD
Omeprazole—ABCC3—lymph node—sarcoma	0.000291	0.00843	CbGeAlD
Omeprazole—ABCG2—bone marrow—sarcoma	0.000273	0.00792	CbGeAlD
Omeprazole—CYP2C19—liver—sarcoma	0.00026	0.00755	CbGeAlD
Omeprazole—ABCB1—myometrium—sarcoma	0.000245	0.0071	CbGeAlD
Omeprazole—CYP2C8—testis—sarcoma	0.00024	0.00697	CbGeAlD
Omeprazole—ABCB1—embryo—sarcoma	0.000236	0.00683	CbGeAlD
Omeprazole—ABCG2—testis—sarcoma	0.000234	0.00677	CbGeAlD
Omeprazole—CYP1B1—lymph node—sarcoma	0.000227	0.00659	CbGeAlD
Omeprazole—CYP2C8—liver—sarcoma	0.000227	0.00659	CbGeAlD
Omeprazole—ABCB1—seminal vesicle—sarcoma	0.000221	0.00641	CbGeAlD
Omeprazole—ABCG2—liver—sarcoma	0.000221	0.0064	CbGeAlD
Omeprazole—CYP1A2—liver—sarcoma	0.000213	0.00616	CbGeAlD
Omeprazole—ABCB1—hematopoietic system—sarcoma	0.00021	0.0061	CbGeAlD
Omeprazole—CYP1A1—liver—sarcoma	0.00021	0.00608	CbGeAlD
Omeprazole—CYP2C9—liver—sarcoma	0.000202	0.00585	CbGeAlD
Omeprazole—ABCG2—lymph node—sarcoma	0.000169	0.00491	CbGeAlD
Omeprazole—CYP1A1—lymph node—sarcoma	0.000161	0.00466	CbGeAlD
Omeprazole—CYP2D6—testis—sarcoma	0.00016	0.00464	CbGeAlD
Omeprazole—ABCB1—uterus—sarcoma	0.000159	0.0046	CbGeAlD
Omeprazole—CYP3A4—liver—sarcoma	0.000154	0.00446	CbGeAlD
Omeprazole—CYP2D6—liver—sarcoma	0.000151	0.00439	CbGeAlD
Omeprazole—Upper respiratory tract infection—Epirubicin—sarcoma	0.00015	0.000812	CcSEcCtD
Omeprazole—Influenza—Doxorubicin—sarcoma	0.00015	0.000809	CcSEcCtD
Omeprazole—Dysphagia—Doxorubicin—sarcoma	0.00015	0.000809	CcSEcCtD
Omeprazole—Asthma—Doxorubicin—sarcoma	0.00015	0.000809	CcSEcCtD
Omeprazole—Pollakiuria—Epirubicin—sarcoma	0.000149	0.000807	CcSEcCtD
Omeprazole—Hypersensitivity—Vincristine—sarcoma	0.000149	0.000806	CcSEcCtD
Omeprazole—ABCB1—lymphoid tissue—sarcoma	0.000148	0.00429	CbGeAlD
Omeprazole—Photosensitivity reaction—Epirubicin—sarcoma	0.000148	0.000798	CcSEcCtD
Omeprazole—Paraesthesia—Etoposide—sarcoma	0.000147	0.000796	CcSEcCtD
Omeprazole—Weight increased—Epirubicin—sarcoma	0.000147	0.000795	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—sarcoma	0.000147	0.000793	CcSEcCtD
Omeprazole—Weight decreased—Epirubicin—sarcoma	0.000146	0.000791	CcSEcCtD
Omeprazole—Dyspnoea—Etoposide—sarcoma	0.000146	0.00079	CcSEcCtD
Omeprazole—Somnolence—Etoposide—sarcoma	0.000146	0.000788	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—sarcoma	0.000146	0.000788	CcSEcCtD
Omeprazole—Hypersensitivity—Mitoxantrone—sarcoma	0.000145	0.000785	CcSEcCtD
Omeprazole—Asthenia—Vincristine—sarcoma	0.000145	0.000785	CcSEcCtD
Omeprazole—Vomiting—Thiotepa—sarcoma	0.000145	0.000785	CcSEcCtD
Omeprazole—Infestation NOS—Epirubicin—sarcoma	0.000144	0.000779	CcSEcCtD
Omeprazole—Infestation—Epirubicin—sarcoma	0.000144	0.000779	CcSEcCtD
Omeprazole—Vomiting—Dactinomycin—sarcoma	0.000144	0.000779	CcSEcCtD
Omeprazole—Rash—Thiotepa—sarcoma	0.000144	0.000778	CcSEcCtD
Omeprazole—Dermatitis—Thiotepa—sarcoma	0.000144	0.000777	CcSEcCtD
Omeprazole—Headache—Thiotepa—sarcoma	0.000143	0.000773	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000143	0.000772	CcSEcCtD
Omeprazole—Rash—Dactinomycin—sarcoma	0.000143	0.000772	CcSEcCtD
Omeprazole—Decreased appetite—Etoposide—sarcoma	0.000143	0.000771	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—sarcoma	0.000142	0.000768	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—sarcoma	0.000142	0.000766	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Etoposide—sarcoma	0.000142	0.000765	CcSEcCtD
Omeprazole—Asthenia—Mitoxantrone—sarcoma	0.000142	0.000765	CcSEcCtD
Omeprazole—Fatigue—Etoposide—sarcoma	0.000142	0.000764	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—sarcoma	0.000141	0.000759	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—sarcoma	0.000141	0.000759	CcSEcCtD
Omeprazole—Constipation—Etoposide—sarcoma	0.00014	0.000758	CcSEcCtD
Omeprazole—Pain—Etoposide—sarcoma	0.00014	0.000758	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—sarcoma	0.00014	0.000757	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—sarcoma	0.00014	0.000757	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—sarcoma	0.00014	0.000756	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—sarcoma	0.00014	0.000756	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000139	0.000751	CcSEcCtD
Omeprazole—Diarrhoea—Vincristine—sarcoma	0.000139	0.000749	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—sarcoma	0.000138	0.000747	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—sarcoma	0.000138	0.000743	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000137	0.000738	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—sarcoma	0.000136	0.000737	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—sarcoma	0.000136	0.000736	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—sarcoma	0.000136	0.000735	CcSEcCtD
Omeprazole—Nausea—Thiotepa—sarcoma	0.000136	0.000733	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—sarcoma	0.000135	0.000731	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—sarcoma	0.000135	0.000731	CcSEcCtD
Omeprazole—Feeling abnormal—Etoposide—sarcoma	0.000135	0.00073	CcSEcCtD
Omeprazole—Diarrhoea—Mitoxantrone—sarcoma	0.000135	0.000729	CcSEcCtD
Omeprazole—ABCB1—bone marrow—sarcoma	0.000135	0.00391	CbGeAlD
Omeprazole—Nausea—Dactinomycin—sarcoma	0.000135	0.000728	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—sarcoma	0.000135	0.000727	CcSEcCtD
Omeprazole—Gastrointestinal pain—Etoposide—sarcoma	0.000134	0.000725	CcSEcCtD
Omeprazole—Dizziness—Vincristine—sarcoma	0.000134	0.000724	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—sarcoma	0.000133	0.000721	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—sarcoma	0.000133	0.000721	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000132	0.000715	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—sarcoma	0.000132	0.000712	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—sarcoma	0.000131	0.000709	CcSEcCtD
Omeprazole—Urticaria—Etoposide—sarcoma	0.00013	0.000704	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—sarcoma	0.00013	0.000703	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—sarcoma	0.00013	0.000703	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—sarcoma	0.00013	0.000701	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—sarcoma	0.00013	0.000701	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—sarcoma	0.00013	0.000701	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—sarcoma	0.00013	0.000701	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—sarcoma	0.00013	0.000701	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—sarcoma	0.00013	0.000699	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—sarcoma	0.000129	0.000696	CcSEcCtD
Omeprazole—Vomiting—Vincristine—sarcoma	0.000129	0.000696	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—sarcoma	0.000129	0.000694	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—sarcoma	0.000128	0.000691	CcSEcCtD
Omeprazole—Rash—Vincristine—sarcoma	0.000128	0.00069	CcSEcCtD
Omeprazole—Dermatitis—Vincristine—sarcoma	0.000128	0.000689	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—sarcoma	0.000128	0.000689	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—sarcoma	0.000127	0.000687	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—sarcoma	0.000127	0.000687	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—sarcoma	0.000127	0.000686	CcSEcCtD
Omeprazole—Headache—Vincristine—sarcoma	0.000127	0.000686	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000126	0.000682	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—sarcoma	0.000126	0.00068	CcSEcCtD
Omeprazole—Vomiting—Mitoxantrone—sarcoma	0.000125	0.000678	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—sarcoma	0.000125	0.000676	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—sarcoma	0.000125	0.000674	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—sarcoma	0.000125	0.000673	CcSEcCtD
Omeprazole—Rash—Mitoxantrone—sarcoma	0.000124	0.000672	CcSEcCtD
Omeprazole—Dermatitis—Mitoxantrone—sarcoma	0.000124	0.000671	CcSEcCtD
Omeprazole—Headache—Mitoxantrone—sarcoma	0.000124	0.000668	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—sarcoma	0.000122	0.000661	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—sarcoma	0.000122	0.000659	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—sarcoma	0.000121	0.000654	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—sarcoma	0.000121	0.000653	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—sarcoma	0.000121	0.000652	CcSEcCtD
Omeprazole—Nausea—Vincristine—sarcoma	0.00012	0.00065	CcSEcCtD
Omeprazole—Flushing—Epirubicin—sarcoma	0.00012	0.000649	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—sarcoma	0.00012	0.000649	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—sarcoma	0.00012	0.000647	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—sarcoma	0.000119	0.000644	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—sarcoma	0.000119	0.000642	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—sarcoma	0.000118	0.000639	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—sarcoma	0.000118	0.000638	CcSEcCtD
Omeprazole—Asthenia—Etoposide—sarcoma	0.000118	0.000636	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—sarcoma	0.000118	0.000636	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—sarcoma	0.000117	0.000634	CcSEcCtD
Omeprazole—Nausea—Mitoxantrone—sarcoma	0.000117	0.000633	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—sarcoma	0.000117	0.000632	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—sarcoma	0.000117	0.00063	CcSEcCtD
Omeprazole—Chills—Epirubicin—sarcoma	0.000116	0.000628	CcSEcCtD
Omeprazole—Pruritus—Etoposide—sarcoma	0.000116	0.000627	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—sarcoma	0.000115	0.000624	CcSEcCtD
Omeprazole—ABCB1—testis—sarcoma	0.000115	0.00334	CbGeAlD
Omeprazole—Alopecia—Epirubicin—sarcoma	0.000114	0.000618	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—sarcoma	0.000113	0.000613	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—sarcoma	0.000113	0.000612	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—sarcoma	0.000113	0.000609	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—sarcoma	0.000112	0.000607	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—sarcoma	0.000112	0.000605	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—sarcoma	0.000112	0.000603	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—sarcoma	0.000111	0.000601	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—sarcoma	0.000111	0.0006	CcSEcCtD
Omeprazole—Tension—Epirubicin—sarcoma	0.000111	0.000597	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—sarcoma	0.00011	0.000596	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—sarcoma	0.000109	0.000591	CcSEcCtD
Omeprazole—Back pain—Epirubicin—sarcoma	0.000109	0.000589	CcSEcCtD
Omeprazole—ABCB1—liver—sarcoma	0.000109	0.00316	CbGeAlD
Omeprazole—Dizziness—Etoposide—sarcoma	0.000109	0.000586	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—sarcoma	0.000108	0.000585	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—sarcoma	0.000108	0.000585	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—sarcoma	0.000108	0.000583	CcSEcCtD
Omeprazole—Chills—Doxorubicin—sarcoma	0.000108	0.000581	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—sarcoma	0.000106	0.000574	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—sarcoma	0.000106	0.000572	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—sarcoma	0.000105	0.000567	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—sarcoma	0.000105	0.000565	CcSEcCtD
Omeprazole—Vomiting—Etoposide—sarcoma	0.000104	0.000564	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—sarcoma	0.000104	0.000563	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—sarcoma	0.000104	0.000563	CcSEcCtD
Omeprazole—Agitation—Epirubicin—sarcoma	0.000104	0.00056	CcSEcCtD
Omeprazole—Rash—Etoposide—sarcoma	0.000103	0.000559	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—sarcoma	0.000103	0.000558	CcSEcCtD
Omeprazole—Headache—Etoposide—sarcoma	0.000103	0.000555	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—sarcoma	0.000103	0.000555	CcSEcCtD
Omeprazole—Tension—Doxorubicin—sarcoma	0.000102	0.000553	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—sarcoma	0.000102	0.000552	CcSEcCtD
Omeprazole—Malaise—Epirubicin—sarcoma	0.000102	0.000549	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—sarcoma	0.000101	0.000547	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—sarcoma	0.000101	0.000547	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—sarcoma	0.000101	0.000545	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—sarcoma	0.000101	0.000545	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—sarcoma	0.0001	0.000542	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—sarcoma	9.96e-05	0.000538	CcSEcCtD
Omeprazole—Cough—Epirubicin—sarcoma	9.84e-05	0.000531	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—sarcoma	9.83e-05	0.000531	CcSEcCtD
Omeprazole—Nausea—Etoposide—sarcoma	9.75e-05	0.000527	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—sarcoma	9.73e-05	0.000526	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—sarcoma	9.68e-05	0.000523	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—sarcoma	9.64e-05	0.000521	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—sarcoma	9.6e-05	0.000518	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—sarcoma	9.6e-05	0.000518	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—sarcoma	9.6e-05	0.000518	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—sarcoma	9.59e-05	0.000518	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—sarcoma	9.57e-05	0.000517	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	9.53e-05	0.000515	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—sarcoma	9.48e-05	0.000512	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—sarcoma	9.41e-05	0.000508	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—sarcoma	9.39e-05	0.000507	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—sarcoma	9.37e-05	0.000506	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—sarcoma	9.34e-05	0.000504	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—sarcoma	9.28e-05	0.000501	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—sarcoma	9.22e-05	0.000498	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—sarcoma	9.2e-05	0.000497	CcSEcCtD
Omeprazole—Infection—Epirubicin—sarcoma	9.14e-05	0.000494	CcSEcCtD
Omeprazole—Cough—Doxorubicin—sarcoma	9.1e-05	0.000492	CcSEcCtD
Omeprazole—Shock—Epirubicin—sarcoma	9.05e-05	0.000489	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—sarcoma	9.02e-05	0.000487	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—sarcoma	9.01e-05	0.000487	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—sarcoma	9.01e-05	0.000486	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—sarcoma	8.98e-05	0.000485	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—sarcoma	8.94e-05	0.000483	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—sarcoma	8.9e-05	0.00048	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—sarcoma	8.88e-05	0.00048	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—sarcoma	8.88e-05	0.00048	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—sarcoma	8.88e-05	0.00048	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—sarcoma	8.85e-05	0.000478	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	8.82e-05	0.000476	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—sarcoma	8.77e-05	0.000474	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—sarcoma	8.77e-05	0.000474	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—sarcoma	8.69e-05	0.000469	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—sarcoma	8.58e-05	0.000464	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—sarcoma	8.51e-05	0.00046	CcSEcCtD
Omeprazole—Infection—Doxorubicin—sarcoma	8.46e-05	0.000457	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—sarcoma	8.38e-05	0.000453	CcSEcCtD
Omeprazole—Shock—Doxorubicin—sarcoma	8.38e-05	0.000452	CcSEcCtD
Omeprazole—ABCB1—lymph node—sarcoma	8.35e-05	0.00242	CbGeAlD
Omeprazole—Nervous system disorder—Doxorubicin—sarcoma	8.35e-05	0.000451	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—sarcoma	8.34e-05	0.00045	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—sarcoma	8.32e-05	0.000449	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—sarcoma	8.31e-05	0.000449	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—sarcoma	8.27e-05	0.000447	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—sarcoma	8.26e-05	0.000446	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—sarcoma	8.23e-05	0.000444	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—sarcoma	8.2e-05	0.000443	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—sarcoma	8.18e-05	0.000442	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—sarcoma	8.12e-05	0.000438	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—sarcoma	8.1e-05	0.000437	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—sarcoma	8e-05	0.000432	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—sarcoma	7.94e-05	0.000429	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—sarcoma	7.93e-05	0.000428	CcSEcCtD
Omeprazole—Constipation—Epirubicin—sarcoma	7.87e-05	0.000425	CcSEcCtD
Omeprazole—Pain—Epirubicin—sarcoma	7.87e-05	0.000425	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—sarcoma	7.76e-05	0.000419	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—sarcoma	7.7e-05	0.000416	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—sarcoma	7.64e-05	0.000413	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—sarcoma	7.59e-05	0.00041	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—sarcoma	7.58e-05	0.000409	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—sarcoma	7.57e-05	0.000409	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—sarcoma	7.52e-05	0.000406	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—sarcoma	7.49e-05	0.000405	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—sarcoma	7.4e-05	0.0004	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—sarcoma	7.35e-05	0.000397	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—sarcoma	7.34e-05	0.000396	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—sarcoma	7.31e-05	0.000395	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—sarcoma	7.28e-05	0.000393	CcSEcCtD
Omeprazole—Pain—Doxorubicin—sarcoma	7.28e-05	0.000393	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—sarcoma	7.27e-05	0.000393	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—sarcoma	7.27e-05	0.000393	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—sarcoma	7.02e-05	0.000379	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—sarcoma	6.96e-05	0.000376	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—sarcoma	6.78e-05	0.000366	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—sarcoma	6.76e-05	0.000365	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—sarcoma	6.73e-05	0.000363	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—sarcoma	6.73e-05	0.000363	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—sarcoma	6.6e-05	0.000357	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—sarcoma	6.51e-05	0.000352	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—sarcoma	6.3e-05	0.00034	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—sarcoma	6.27e-05	0.000339	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—sarcoma	6.11e-05	0.00033	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—sarcoma	6.08e-05	0.000329	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—sarcoma	6.02e-05	0.000325	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—sarcoma	5.85e-05	0.000316	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—sarcoma	5.83e-05	0.000315	CcSEcCtD
Omeprazole—Rash—Epirubicin—sarcoma	5.8e-05	0.000313	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—sarcoma	5.8e-05	0.000313	CcSEcCtD
Omeprazole—Headache—Epirubicin—sarcoma	5.76e-05	0.000311	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—sarcoma	5.63e-05	0.000304	CcSEcCtD
Omeprazole—Nausea—Epirubicin—sarcoma	5.47e-05	0.000295	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—sarcoma	5.41e-05	0.000292	CcSEcCtD
Omeprazole—Rash—Doxorubicin—sarcoma	5.37e-05	0.00029	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—sarcoma	5.36e-05	0.00029	CcSEcCtD
Omeprazole—Headache—Doxorubicin—sarcoma	5.33e-05	0.000288	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—sarcoma	5.06e-05	0.000273	CcSEcCtD
